Patrick Durisch (@dbdurisch.bsky.social)

Full set of Principles for Access to Medicines and Trade: citizen.org/news/more-than…

The Trump administration is using U.S. trade power and extreme tariffs to bully other countries into binding agreements that undermine affordable and readily available access to medicines. Experts from around the world offer an alternate vision:

Plutôt une vaste farce qu'un accord, un peu comme les soldes : des % en apparence élevés mais sur des prix catalogue fictifs, avec un impact mineur pour les patient·e·s 🇺🇸 mais majeur pour #BigPharma. Qui exigera en retour une hausse indécente en🇨🇭🇪🇺... rts.ch/info/economie/…

.@PublicEyeSuisse extensively reported about Roche's patent evergreening strategy on its breast cancer treatments trastuzumab & follow-on products. This led to complaints by competition authorities a.o. in South Africa. When will 🇨🇭start to act? publiceye.ch/en/topics/phar…

Belgian Regulator Presses Roche Further Over Biosimilar Abuse Allegations insights.citeline.com/pink-sheet/leg…

The $150bn question: has the 🇮🇳 gov considered introducing drug #dataexclusivity on its own, after resisting it for decades in trade talks? Or has🇨🇭@SECO_StateSec helped by suggesting it could attract additional foreign investment, as reported by 🇮🇳 press? thehindubusinessline.com/news/keep-data…

💥 BREAKING from Lima, where countries negotiate amendments to the #SeedTreaty Switzerland🇨🇭, acting as the Chair of the discussions on the Multilateral System, is attempting to push through a new “seed sharing agreement” that countries never had the opportunity to read or discuss. 🏴‍☠️🌱Disagreements on several pages were secretly removed. The rushed text would not only fail to strengthen the Treaty's multilateral system, but it would also enable biopiracy. Full report 👉twn.my/title2/biotk/2…

Nestlé accused of ’risking health of babies for profit’ over added sugar in cereals sold in African countries #Echobox=1763454932" target="_blank" rel="nofollow noopener">theguardian.com/global-develop…

A new Public Eye study shows Roche’s patent "evergreening" strategy for its HER2+ breast cancer drugs (Herceptin & Co), enabling it to rake in >CHF 156 bn & hinder timely access to affordable biosimilars until 2042👉Time for🇨🇭to act against patent thickets publiceye.ch/en/topics/phar…

Siehe unser Dossier für mehr Infos publiceye.ch/de/themen/phar…

@Roche hat es mit Perjeta schon mal gemacht - das ist reine Erpressung, um die schon astronomischen Gewinnmargen weiter zu steigern. Patient*innen werden als Geiseln genommen. Es gibt Lösungen, aber @BAG_OFSP_UFSP @elisabeth_baume wagen es nicht zu handeln tagesanzeiger.ch/roche-zieht-kr…

Pour plus d'informations, voir notre dossier publiceye.ch/fr/thematiques…

@Roche l'avait déjà fait par le passé, c'est du pur chantage destiné uniquement à augmenter ses marges de profits déjà astronomiques, en prenant les patient·e·s en otage. Des solutions existent mais le @BAG_OFSP_UFSP @elisabeth_baume n'osent pas agir 24heures.ch/cancer-roche-r…

Even Swiss civil society is echoing #BewareOfMEEPA 🇨🇭Prominent Swiss CSOs, like @publiceye_ch, urged their govt to stop pushing Malaysia into IP rules that threaten access to medicines & seeds “Switzerland imperils the rights to food and health” publiceye.ch/en/news/detail…

#BewareOfMeepa Leaked text of Malaysia’s trade deal with EFTA reveals push for TRIPS+ @anwaribrahim @tzafrul_aziz @DrDzul This will lock 🇲🇾 into expanded patent monopolies & strip away critical legal @WTO flexibilities See @consumer_penang's analysis ▶️tinyurl.com/3ds9md43

A coalition of Swiss NGOs led by @PublicEyeSuisse requested today🇨🇭@SECO_StateSec @ParmelinG to drop harmful #TRIPS+ provisions contained in the free trade deal between @EFTAsecretariat🇳🇴🇨🇭🇮🇸 🇱🇮 and Malaysia 🇲🇾 that threaten the rights to health & to food publiceye.ch/en/news/detail…

Thai CSOs Warn the Senate’s Subcommittee about the Ongoing FTA Negotiation with the EU on TRIPs-plus Provisions Harmful to Access to Medicines a2med.wordpress.com/2025/01/09/tha…

NEW: @Public_Citizen reveals the billions of 💰 drug companies have extracted from Medicare by abusing the patent system to hike drug prices. Medicare must heavily weigh the costs of patent abuse when negotiating maximum fair prices. citizen.org/article/using-…

Patented drug prices are major drivers of🇨🇭health insurance expenses (3/4 of total prescription drug costs). But instead of requiring > transparency on #BigPharma real R&D costs to set fair prices,🇨🇭wants to legalise #secretrebates, in total contradiction with resolution WHA72.8